SCHEMBL19633304

SCHEMBL19633304

CNC(CCCNC(N)=O)C(=O)Nc1ccc(COC=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.41
ADAM10 O14672 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP12 P39900 1/20 0.40
MMP14 P50281 1/20 0.40
ADAM8 P78325 1/20 0.40
ADAM17 P78536 1/20 0.40
SIRT2 Q8IXJ6 8/20 0.39
SIRT1 Q96EB6 8/20 0.39
SIRT3 Q9NTG7 3/20 0.39
SIRT5 Q9NXA8 3/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
C3AR1 Q16581 1/20 0.36
LTA4H P09960 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23221828 0.90 ADAM10 (0.39) ADAM10MMP2MMP9MMP12MMP14
SCHEMBL18431308 0.89 FURIN (0.41) ADAM10MMP2MMP9MMP12MMP14
SCHEMBL22810892 0.89 SIRT2 (0.41) ADAM10MMP2MMP9MMP12MMP14
SCHEMBL21883411 0.87 SIRT2 (0.39) SIRT2SIRT1SIRT3SIRT5NPC1
SCHEMBL24329149 0.87 SIRT2 (0.41) ADAM10MMP2MMP9MMP12MMP14
SCHEMBL19389191 0.86 SIRT2 (0.41) SIRT2SIRT1SIRT3SIRT5SMN1; SMN2
SCHEMBL20844980 0.86 LTA4H (0.47) SPHK1ADAM10MMP2MMP9MMP12
SCHEMBL21167799 0.86 SIRT2 (0.44) SPHK1ADAM10MMP2MMP9MMP12
SCHEMBL25100584 0.85 SIRT2 (0.43) SPHK1ADAM10MMP2MMP9MMP12
SCHEMBL19443237 0.85 SIRT2 (0.43) SPHK1ADAM10MMP2MMP9MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023173026-A1 ANTIBODY-DRUG CONJUGATES AND USES THEREOF SORRENTO THERAPEUTICS, INC. (US) 2023-09-14 WO disclosed
EP-3753578-A1 CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF Novartis AG (CH) 2020-12-23 EP disclosed
WO-2017201204-A1 ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE ABBVIE BIOTHERAPEUTICS INC. (US) 2017-11-23 WO disclosed